References: Goyarts E, Matsui M, Mammone T, Bender AM, Wagner JA, Maes D, Granstein RD. Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp Dermatol. 2008 Mar;17(3):188-96. (RSG ELISA kit, TC supernatant, PubMed)
Enstrom A, Onore C, Hertz-Picciotto I, Hansen R, Croen L, Van de WaterJ, Ashwood P. Detection of IL-17 and IL-23 in Plasma Samples of Children with Autism. American Journal of Biochemistry and Biotechnology 4 (2): 114-120, 2008. (RSG ELISA kit, plasma)
Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006 May;116(5):1218-22.
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006 Feb;24(2):179-89.
Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005 Nov;6(11):1123-32.
Brombacher F, Kastelein RA, Alber G. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 2003 Apr;24(4):207-12.
Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. IL-23 promotes a distinct CD4 T cell activation state chaacterized by the production of IL-17. J. J Biol Chem. 2003 Jan 17;278(3):1910-4.
Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000 Nov;13(5):715-25.